Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

COVID-19

Turkish Journal of Medical Sciences

2021

Articles 1 - 30 of 56

Full-Text Articles in Medicine and Health Sciences

Consensus Recommendations For Botulinum Toxin Injections In The Spasticitymanagement Of Children With Cerebral Palsy During Covid-19 Outbreak, Ebru Yilmaz Yalçinkaya, Nai̇me Evri̇m Karadağ Saygi, Özden Özyemi̇şci̇ Taşkiran, Nalan Çapan, Şehi̇m Kutlay, Bi̇rkan Sonel Tur, Özlem El, Ece Ünlü Akyüz, Süda Teki̇n, Demet Ofluoğlu, Murat Zi̇nnuroğlu, Pinar Akpinar, Tuğçe Özekli̇ Misirlioğlu, Berri̇n Hüner, Ahmet Hakan Nur Jan 2021

Consensus Recommendations For Botulinum Toxin Injections In The Spasticitymanagement Of Children With Cerebral Palsy During Covid-19 Outbreak, Ebru Yilmaz Yalçinkaya, Nai̇me Evri̇m Karadağ Saygi, Özden Özyemi̇şci̇ Taşkiran, Nalan Çapan, Şehi̇m Kutlay, Bi̇rkan Sonel Tur, Özlem El, Ece Ünlü Akyüz, Süda Teki̇n, Demet Ofluoğlu, Murat Zi̇nnuroğlu, Pinar Akpinar, Tuğçe Özekli̇ Misirlioğlu, Berri̇n Hüner, Ahmet Hakan Nur

Turkish Journal of Medical Sciences

Spasticity is the most common motor disturbance in cerebral palsy (CP). Lockdown in the COVID-19 outbreak has profoundly changed daily routines, and similarly caused the suspension of spasticity treatment plans. Besides, the delay in botulinum toxin (BoNT) injection, which is important in the management of focal spasticity, led to some problems in children. This consensus report includes BoNT injection recommendations in the management of spasticity during the COVID-19 pandemic in children with CP. In order to develop the consensus report, physical medicine and rehabilitation (PMR) specialists experienced in the field of pediatric rehabilitation and BoNT injections were invited by Pediatric …


Clinical Course Of Covid-19 Disease In Immunosuppressed Renal Transplant Patients, Hamad Dhei̇r, Savaş Si̇pahi̇, Selçuk Yaylaci, Esma Seda Çeti̇n, Ahmed Bi̇lal Genç, Necatti̇n Firat, Mehmet Köroğlu, Gürkan Muratdaği, Yakup Tomak, Kezban Özmen Süner, Ömer Faruk Ateş, Oğuz Karabay Jan 2021

Clinical Course Of Covid-19 Disease In Immunosuppressed Renal Transplant Patients, Hamad Dhei̇r, Savaş Si̇pahi̇, Selçuk Yaylaci, Esma Seda Çeti̇n, Ahmed Bi̇lal Genç, Necatti̇n Firat, Mehmet Köroğlu, Gürkan Muratdaği, Yakup Tomak, Kezban Özmen Süner, Ömer Faruk Ateş, Oğuz Karabay

Turkish Journal of Medical Sciences

Background/aim: We aimed to identify clinical settings of renal transplant patients with COVID-19. Materials and methods: In this retrospective study, we included kidney transplant inpatients with laboratory confirmed COVID-19 who had been discharged or had died by October 1st, 2020. Characteristics of the patients, including basal and last outpatient biochemical parameters were recorded. Discontinuation or dosage reduction of immunosuppressives and other treatment information was documented. Results: Twenty patients were included in this study, of whom 18 were discharged and 2 died in hospital. The mean duration of hospitalization and follow-up were 9.7 ± 6.4 days and 4.5 ± 2.0 months, …


The Predictive And Diagnostic Accuracy Of Long Pentraxin-3 In Covid-19 Pneumonia, Ahmed Bi̇lal Genç, Selçuk Yaylaci, Hamad Dhei̇r, Ahmed Ci̇had Genç, Kubi̇lay İşsever, Deni̇z Çeki̇ç, Havva Kocayi̇ği̇t, Erdem Çokluk, Alper Karacan, Mehmet Ramazan Şekeroğlu, Hande Toptan, Ertuğrul Güçlü Jan 2021

The Predictive And Diagnostic Accuracy Of Long Pentraxin-3 In Covid-19 Pneumonia, Ahmed Bi̇lal Genç, Selçuk Yaylaci, Hamad Dhei̇r, Ahmed Ci̇had Genç, Kubi̇lay İşsever, Deni̇z Çeki̇ç, Havva Kocayi̇ği̇t, Erdem Çokluk, Alper Karacan, Mehmet Ramazan Şekeroğlu, Hande Toptan, Ertuğrul Güçlü

Turkish Journal of Medical Sciences

Background/aim: The purpose of this study is to evaluate serum pentraxin-3 (PTX-3) levels in Sars-CoV-2 virus infection (COVID-19) patients and to investigate whether PTX-3 predicts the disease prognosis. Materials and methods: This study was conducted on 88 confirmed COVID-19 patients who were hospitalized due to symptomatic pneumonia between April 15 and August 15, 2020. The patients were divided into two groups as survived patients and non-survived patients. Both groups were compared according to demographic features, comorbid conditions and measurement of the PTX-3 and other laboratory parameters of the patients. Results: Of 88 patients with COVID-19, 59 (67%) were discharged with …


Projecting The Course Of Covid-19 In Turkey: A Probabilistic Modeling Approach, Aybar Can Acar, Ahmet Görkem Er, Hüseyi̇n Cahi̇t Burduroğlu, Seher Nur Sülkü, Yeşi̇m Aydin Son, Levent Akin, Serhat Ünal Jan 2021

Projecting The Course Of Covid-19 In Turkey: A Probabilistic Modeling Approach, Aybar Can Acar, Ahmet Görkem Er, Hüseyi̇n Cahi̇t Burduroğlu, Seher Nur Sülkü, Yeşi̇m Aydin Son, Levent Akin, Serhat Ünal

Turkish Journal of Medical Sciences

Background/aim: The COVID-19 pandemic originated in Wuhan, China, in December 2019 and became one of the worst global health crises ever. While struggling with the unknown nature of this novel coronavirus, many researchers and groups attempted to project the progress of the pandemic using empirical or mechanistic models, each one having its drawbacks. The first confirmed cases were announced early in March, and since then, serious containment measures have taken place in Turkey. Materials and methods: Here, we present a different approach, a Bayesian negative binomial multilevel model with mixed effects, for the projection of the COVID-19 pandemic and we …


Turkey's Response To Covid-19 Pandemic: Strategy And Key Actions, Gülşen Barlas, Harun Öztürk, Gülen Pehli̇vantürk, Sabahatti̇n Aydin Jan 2021

Turkey's Response To Covid-19 Pandemic: Strategy And Key Actions, Gülşen Barlas, Harun Öztürk, Gülen Pehli̇vantürk, Sabahatti̇n Aydin

Turkish Journal of Medical Sciences

COVID-19 emerged at the end of 2019 in Wuhan, China, and spread rapidly around the world causing many deaths. Due to the intercontinental escalation in the epidemic, while WHO declared a pandemic on March 11, 2020, our country's first case was diagnosed. Before this, the MoH established the Operations Center against possible risks regarding the Pandemic Influenza Preparedness Plan on January 10, 2020 and formed the Scientific Committee, which has a critical importance in epidemic management. National and Provincial Pandemic Coordination Boards were established within the scope of this plan. Fast, effective and frequently updated decisions were implemented. The epidemic …


One And A Half Years Into The Covid-19 Pandemic - Exit Strategies And Efficacy Of Sarscov-2 Vaccines For Holistic Management And Achieving Global Control, Eskild Petersen, Ayşe Deni̇z Gökengi̇n, Asma Al Balushi, Alimuddin Zumla Jan 2021

One And A Half Years Into The Covid-19 Pandemic - Exit Strategies And Efficacy Of Sarscov-2 Vaccines For Holistic Management And Achieving Global Control, Eskild Petersen, Ayşe Deni̇z Gökengi̇n, Asma Al Balushi, Alimuddin Zumla

Turkish Journal of Medical Sciences

One and a half years into the pandemic, SARS-CoV-2 is still here to stay. Whilst rapid several effective COVID-19 vaccines have been developed and are being rolled out, the critical questions remain whether vaccines provide widespread protection against infection and reinfection, and what the duration of protection is. Community wide control cannot be obtained until almost everyone is immune. Vaccine production must be ramped up to cover the world population. The price of herd immunity through natural infection is high mortality in the elderly and morbidity in other age groups including children and Long-COVID. We must expect a new wave …


Achievements Of The Covid-19 Turkey Platform In Vaccine And Drug Development Withan Approach Of "Co-Creation And Succeeding Together", Hasan Mandal Jan 2021

Achievements Of The Covid-19 Turkey Platform In Vaccine And Drug Development Withan Approach Of "Co-Creation And Succeeding Together", Hasan Mandal

Turkish Journal of Medical Sciences

Mobilizing the research ecosystem for accelerating vaccine and drug development has been an important reality of the pandemic. This article reviews the scientific advances that are attained by the COVID-19 Turkey Platform for vaccine and drug development against the SARS-CoV-2 virus. The platform that is coordinated by the Scientific and Technological Research Council of Turkey is established with a "co-creation and succeeding together" approach, which involves 436 researchers across 49 different institutions working on 17 vaccine and drug development projects in total. Recent advances of the COVID-19 Turkey Platform include the fourth virus-like particle-based vaccine candidate in the world to …


Nonpharmaceutical Interventions In Turkey And Worldwide During Covid-19 Pandemic, Mustafa Necmi̇ İlhan, Hakan Tüzün, Rahmi̇ Kiliç, Nuran Yildirim Jan 2021

Nonpharmaceutical Interventions In Turkey And Worldwide During Covid-19 Pandemic, Mustafa Necmi̇ İlhan, Hakan Tüzün, Rahmi̇ Kiliç, Nuran Yildirim

Turkish Journal of Medical Sciences

Nonpharmaceutical interventions (NPIs) are actions apart from getting vaccinated and medications, in order to promote deceleration of the spread of illness among people and communities during pandemic. In this article, we aim to examine NPIs applied in Turkey and worldwide due to the COVID-19 pandemic. Some of the NPIs such as isolation, quarantine, and contact tracing were maintained with updates of the Ministry of Health guidelines in Turkey. Some NPIs including travel and partial or full curfew mobilization restrictions were set in accordance with the various periods by the number of cases. Periods of restrictions at autumn 2021 to summer …


Current Infection Prevention And Control Strategies Of Covid-19 In Hospitals, Gamze Kalin Ünüvar, Mehmet Doğanay, Emi̇ne Alp Jan 2021

Current Infection Prevention And Control Strategies Of Covid-19 In Hospitals, Gamze Kalin Ünüvar, Mehmet Doğanay, Emi̇ne Alp

Turkish Journal of Medical Sciences

Background/aim: Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been appeared first in China since December 2019. Transmission of SARS-CoV-2 occurs primarily with droplets through coughing and sneezing and also occurs through inhalation of aerosolized secretions, which travel, remain suspended in the air longer. Materials and methods: Since early stages of the outbreak, COVID-19 cases have been described in healthcare workers (HCWs). However, in the early stages, the disease may be asymptomatic. This may lead to incorrect diagnosis or delayed diagnosis and may lead to the nosocomial spread of the virus. One of the …


Evaluating The Efficiency Of Public Policy Measures Against Covid-19, Hati̇ce Rahmet Güner, İmran Hasanoğlu, Fi̇rdevs Aktaş Jan 2021

Evaluating The Efficiency Of Public Policy Measures Against Covid-19, Hati̇ce Rahmet Güner, İmran Hasanoğlu, Fi̇rdevs Aktaş

Turkish Journal of Medical Sciences

The World Health Organization (WHO) declared COVID-19 as a Public Health Emergency of international concern on January 30, 2020, and a pandemic on March 11, 2020. Afterward, it spread rapidly all over the world, causing almost 4 million deaths as of June 2021. It is clear that effective preventive measures are needed in this devastating disease, which still has no cure. In addition to mask using, social distancing, and hygiene practices, which enter our lives as the most basic precautions, communities aim to reduce the effects of the COVID-19 pandemic. All over the world, the measures taken and activities performed …


Multisystem Inflammatory Syndrome In Children, Selda Hançerli̇ Törün, Di̇lek Yilmaz Çi̇ftdoğan, Ateş Kara Jan 2021

Multisystem Inflammatory Syndrome In Children, Selda Hançerli̇ Törün, Di̇lek Yilmaz Çi̇ftdoğan, Ateş Kara

Turkish Journal of Medical Sciences

As the COVID-19 pandemic continues, children can be infected with the virus that causes COVID-19. Clinical symptoms of children with COVID from China, where the disease was first reported, generally were less severe than adults. However, at the end of April 2020 in Europe, it was observed that some children with SARS-CoV-2 infection developed fever, abdominal pain, shock, myocardial insufficiency and they needed to be taken care of in intensive care unit. This new disease has been called multisystem inflammatory syndrome in children (MIS-C). Although the pathogenesis of MIS-C is unclear, it progresses with signs of multiorgan involvement as a …


Covid-19 And Sepsis, Zeli̇ha Koçak Tufan, Bi̇rcan Kayaaslan, Mervyn Mer Jan 2021

Covid-19 And Sepsis, Zeli̇ha Koçak Tufan, Bi̇rcan Kayaaslan, Mervyn Mer

Turkish Journal of Medical Sciences

The COVID-19 pandemic has created a major alteration in the medical literature including the sepsis discussion. From the outset of the pandemic, various reports have indicated that although there are some unique features pertinent to COVID-19, many of its acute manifestations are similar to sepsis caused by other pathogens. As a consequence, the old definitions now require consideration of this new etiologic agent, namely SARS-CoV-2. Although the pathogenesis of COVID-19 has not been fully explained, the data obtained so far in hospitalized patients has revealed that serum cytokine and chemokine levels are high in severe COVID-19 patients, similar to those …


The Radiological Findings Of Covid-19, Alper Karacan, Yakup Ersel Aksoy, Mehmet Hali̇l Öztürk Jan 2021

The Radiological Findings Of Covid-19, Alper Karacan, Yakup Ersel Aksoy, Mehmet Hali̇l Öztürk

Turkish Journal of Medical Sciences

Background/aim: Available information on the radiological findings of the 2019 novel coronavirus disease (COVID-19) is constantly updated. Ground glass opacities (GGOs) and consolidation with bilateral and peripheral distribution have been reported as the most common CT findings, but less typical features can also be identified. According to the reported studies, SARS-CoV-2 infection is not limited to the respiratory system, and it can also affect other organs. Renal dysfunction, gastrointestinal complications, liver dysfunction, cardiac manifestations, and neurological abnormalities are among the reported extrapulmonary features. This review aims to provide updated information for radiologists and all clinicians to better understand the radiological …


Pregnancy And Covid-19: Prevention, Vaccination, Therapy, And Beyond, Di̇lek Şahi̇n, Atakan Tanaçan, Sophia Ne Webster, Özlem Moraloğlu Teki̇n Jan 2021

Pregnancy And Covid-19: Prevention, Vaccination, Therapy, And Beyond, Di̇lek Şahi̇n, Atakan Tanaçan, Sophia Ne Webster, Özlem Moraloğlu Teki̇n

Turkish Journal of Medical Sciences

: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has alarmed the world since its first emergence. As pregnancy is characterized by significant changes in cardiovascular, respiratory, endocrine, and immunological systems, there are concerns on issues like the course of disease in pregnant women, safety of medications, route of delivery and risk of obstetric complications. The aim of this review is to summarize the current literature in the management of pregnant women during the COVID-19 pandemic. Although more than 90% of pregnant women with COVID-19 recover without serious morbidity, rapid deterioration of disease and higher …


From Asymptomatic To Critical Illness: Decoding Various Clinical Stages Of Covid-19, İlhami̇ Çeli̇k, Recep Öztürk Jan 2021

From Asymptomatic To Critical Illness: Decoding Various Clinical Stages Of Covid-19, İlhami̇ Çeli̇k, Recep Öztürk

Turkish Journal of Medical Sciences

The clinical course of COVID-19 is variable, with clinical manifestation ranging from 81% mild course to 14% severe course along with 5% critical course in patients. The asymptomatic course is reported to potentially range between 20% and 70% (avg. 33%). A more severe course is seen in the elderly, those with various chronic diseases, and the immunosuppressed, where the case fatality rate is higher in these risk groups. The disease progresses with various symptoms, such as fever, cough, shortness of breath, malaise, myalgia, taste and smell disorders, diarrhea, sore throat, headache, and conjunctivitis. The disease begins with shortness of breath, …


Immune Dysfunction In Covid-19 And Judicious Use Of Antirheumatic Drugs For Thetreatment Of Hyperinflammation, Abdurrahman Tufan, Marco Matucci-Cerinic Jan 2021

Immune Dysfunction In Covid-19 And Judicious Use Of Antirheumatic Drugs For Thetreatment Of Hyperinflammation, Abdurrahman Tufan, Marco Matucci-Cerinic

Turkish Journal of Medical Sciences

: In the Wuhan province of China, almost two years ago, in December 2019, the novel Coronavirus 2019 has caused a severe involvement of the lower respiratory tract leading to an acute life-threatening respiratory syndrome, coronavirus disease-19 (COVID-19). Subsequently, coronavirus 2 (SARS-CoV-2) rapidly spread to the entire world causing a pandemic and affected every single person on earth either directly or indirectly with destroying all facets of social life and economy. Since the announcement of COVID-19 as a global pandemic, we have witnessed tremendous scientific work on all aspects of COVID-19 across the globe, which has never been witnessed before. …


Which Hematological Markers Have Predictive Value As Early Indicators Of Severecovid-19 Cases In The Emergency Department?, İshak Şan, Emi̇n Gemci̇oğlu, Mehmet Davutoğlu, Rami̇s Çatalbaş, Berkan Karabuğa, Enes Kaptan, Abdulsamet Erden, Orhan Küçükşahi̇n, İhsan Ateş, Selma Karaahmetoğlu, İmran Hasanoğlu, Osman İnan, Büşra Nur Ünal, Ecem Erdemi̇r, Fati̇h Ahmet Kahraman Jan 2021

Which Hematological Markers Have Predictive Value As Early Indicators Of Severecovid-19 Cases In The Emergency Department?, İshak Şan, Emi̇n Gemci̇oğlu, Mehmet Davutoğlu, Rami̇s Çatalbaş, Berkan Karabuğa, Enes Kaptan, Abdulsamet Erden, Orhan Küçükşahi̇n, İhsan Ateş, Selma Karaahmetoğlu, İmran Hasanoğlu, Osman İnan, Büşra Nur Ünal, Ecem Erdemi̇r, Fati̇h Ahmet Kahraman

Turkish Journal of Medical Sciences

Background/aim: Coronavirus 2019 disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a pandemic infectious disease that causes morbidity and mortality. As a result of high mortality rate among the severe COVID-19 patients, the early detection of the disease stage and early effective interventions are very important in reducing mortality. Hence, it is important to differentiate severe and nonsevere cases from each other. To date, there are no proven diagnostic or prognostic parameters that can be used in this manner. Due to the expensive and not easily accessible tests that are performed for COVID-19, researchers are investigating …


The Analysis Of Pleural Complications Of Covid-19 Pneumonia, Merve Şatir Türk, Irmak Akarsu, İsmai̇l Tombul, Aykut Kankoç, Nur Di̇lvi̇n Özkan, Elgun Valiyev, Muhammet Sayan, Ali̇ Çeli̇k, İsmai̇l Cüneyt Kurul, Olgun Kadi̇r Aribaş, Abdullah İrfan Taştepe Jan 2021

The Analysis Of Pleural Complications Of Covid-19 Pneumonia, Merve Şatir Türk, Irmak Akarsu, İsmai̇l Tombul, Aykut Kankoç, Nur Di̇lvi̇n Özkan, Elgun Valiyev, Muhammet Sayan, Ali̇ Çeli̇k, İsmai̇l Cüneyt Kurul, Olgun Kadi̇r Aribaş, Abdullah İrfan Taştepe

Turkish Journal of Medical Sciences

Background/aim: As the number of case reports related to the new type of coronavirus (COVID-19) increases, knowledge of and experience with the virus and its complications also increase. Pleural complications are one relevant issue. We aimed in this study to analyze pleural complications, such as pneumothorax, pneumomediastinum, and empyema, in patients hospitalized with the diagnosis of COVID-19 pneumonia. Materials and methods: The files of patients who have pleural complications of COVID-19 pneumonia and were consulted about thoracic surgery between March 2020 and December 2020 were retrospectively reviewed. The data of the patients were analyzed according to age, sex, length of …


Decrease Of Left Ventricular Ejection Fraction In Severe Illness Patients Due To Covid-19may Improve As The Disease Resolves, Aykut Demi̇rkiran, Lütfi̇ Çağatay Onar, Mustafa Doğan Jan 2021

Decrease Of Left Ventricular Ejection Fraction In Severe Illness Patients Due To Covid-19may Improve As The Disease Resolves, Aykut Demi̇rkiran, Lütfi̇ Çağatay Onar, Mustafa Doğan

Turkish Journal of Medical Sciences

Background/aim: Increase in publications supporting myocardial involvement in the COVID-19 disease has led to need to gain insight into the the global burden of heart failure after pandemic. We examined the course of myocardial systolic function in patients without elevated troponin levels. Materials and methods: We performed a prospective study. Patients with high troponin levels were excluded from the study in order to definitively exclude complications known to cause permanent left ventricular systolic dysfunction, such as acute coronary syndromes. Two echocardiographic examinations were performed. The first evaluation was performed within the days of hospitalization, if possible, on the day when …


Going Back To Normal, But How? Re-Opening Policies And The Standards For A New Normal, Levent Akin Jan 2021

Going Back To Normal, But How? Re-Opening Policies And The Standards For A New Normal, Levent Akin

Turkish Journal of Medical Sciences

Governments implemented to nonpharmacological methods and various limitation policies such as closing nonessential businesses, schools and limiting group gatherings, promoting social distancing, use of personal protective equipment, advising staying at home. These policies have caused various problems in social and economic life and gradual increase in psychosocial well-being problems. All societies yearningly are waiting for the COVID-19 pandemic to be brought under control and the measures to be lifted in order to return to their previous lives. Indicators are needed to assess the burden of disease in the country while lifting measures to control the COVID-19 pandemic. When using these …


How Efficient Are Facial Masks Against Covid-19? Evaluating The Mask Use Of Variouscommunities One Year Into The Pandemic, Aslıhan Candevi̇r, Cem Üngör, Fi̇gen Çi̇zmeci̇ Şenel, Yeşi̇m Taşova Jan 2021

How Efficient Are Facial Masks Against Covid-19? Evaluating The Mask Use Of Variouscommunities One Year Into The Pandemic, Aslıhan Candevi̇r, Cem Üngör, Fi̇gen Çi̇zmeci̇ Şenel, Yeşi̇m Taşova

Turkish Journal of Medical Sciences

Face masks are devices worn over the mouth and nose to protect against splashes, infectious respiratory droplets, or aerosols generated during breathing or coughing according to their filtering capacity. Medical masks, respirators, or cloth masks have been used for source control and for the protection of the exposed. After the first case on March 11, 2020, in Turkey, National COVID-19 Scientific Advisory Board published various contents for the correct use of masks. Medical face masks have been used in healthcare settings for both source control and potential personal protection before the COVID-19 pandemic. Adverse events associated with using masks are …


Rna-Based Covid-19 Vaccine Candidates With Clinical Phase Trials In Progress, Leyla İpek Rudvan Al, Meli̇ha Çağla Sönmezer, Serhat Ünal Jan 2021

Rna-Based Covid-19 Vaccine Candidates With Clinical Phase Trials In Progress, Leyla İpek Rudvan Al, Meli̇ha Çağla Sönmezer, Serhat Ünal

Turkish Journal of Medical Sciences

Due to the COVID-19 infection, which was recognized as a global pandemic by the WHO on March 11, 2020, the number of cases and disease-related deaths increases day by day globally. For this reason, antiviral agents used in treatment and vaccines, the most effective weapon in prevention, continue to be the most popular topic of the plan. Several situations are expected to affect the course of the pandemic. The loss of the ability of the virus to mutate and cause disease, the fact that those who become immunized by having the disease in the society reach a critical rate and …


Epidemiology Of Covid-19: What Changed In One Year?, Cemal Bulut, Yasuyuki̇ Kato Jan 2021

Epidemiology Of Covid-19: What Changed In One Year?, Cemal Bulut, Yasuyuki̇ Kato

Turkish Journal of Medical Sciences

A coronavirus brought the first pandemic attack of this century as a flu virus did a hundred years ago. This greatest pandemic of the century brings us new opportunities to understand and explore the dynamics of a contagious disease. Nearly two years later, we are still collecting the evidence to understand the disease. Some basic epidemiological properties are still urgently needed. Not only the origin of the virus but also Ro value, possible transmission routes, epidemiologic curves, case fatality rates, seasonality, severity and mortality risk factor, effects on the risk groups, differences between countries and so on still require strong …


From Asymptomatic To Critical Illness - Different Clinical Manifestations Of Covid-19 Inchildren, Hasan Tezer, Meli̇s Deni̇z Jan 2021

From Asymptomatic To Critical Illness - Different Clinical Manifestations Of Covid-19 Inchildren, Hasan Tezer, Meli̇s Deni̇z

Turkish Journal of Medical Sciences

The global pandemic infectious disease that was named the new coronavirus disease (COVID 19), spread throughout the world, causing a major public health emergency. The causative virus of COVID-19, called SARS CoV-2, can infect all age groups. Various clinical signs and symptoms have been observed in neonates, children, and adolescents during the COVID-19 outbreak. The clinical manifestations of COVID-19 might be different due to the medical conditions and comorbid status in elderly and pediatric patients. The rise in cases among children has been reported during the COVID-19 pandemic. Although infected children generally appear to be asymptomatic or have only mild …


An Update Of Anti-Viral Treatment Of Covid-19, Serap Yavuz, Feri̇de İpek Komsuoğlu Çeli̇kyurt Jan 2021

An Update Of Anti-Viral Treatment Of Covid-19, Serap Yavuz, Feri̇de İpek Komsuoğlu Çeli̇kyurt

Turkish Journal of Medical Sciences

Background/aim: Currently there is not an effective antiviral treatment for COVID-19, but a large number of drugs have been evaluated since the beginning of the pandemic, and many of them have been used for the treatment of COVID-19 despite the preliminary or conflicting results of the clinical trials. We aimed to review and summarize all of the current knowledge on the antivirals for COVID-19. Results: There are 2 main drug groups for SARS-CoV-2: agents that target proteins or RNA of the virus or interfere with proteins or biological processes in the host that support the virus. The main drug groups …


Hydroxychloroquine Plus Azithromycin And Early Hospital Admission Are Beneficial Incovid-19 Patients: Turkish Experience With Real-Life Data, Eli̇f Tanriverdi̇, Mustafa Çörtük, Bi̇nnaz Zeynep Yildirim, Efsun Gonca Uğur Chousein, Demet Turan, Hali̇t Çinarka, Mehmet Aki̇f Özgül, Erdoğan Çeti̇nkaya Jan 2021

Hydroxychloroquine Plus Azithromycin And Early Hospital Admission Are Beneficial Incovid-19 Patients: Turkish Experience With Real-Life Data, Eli̇f Tanriverdi̇, Mustafa Çörtük, Bi̇nnaz Zeynep Yildirim, Efsun Gonca Uğur Chousein, Demet Turan, Hali̇t Çinarka, Mehmet Aki̇f Özgül, Erdoğan Çeti̇nkaya

Turkish Journal of Medical Sciences

Background/aim: New treatment regimens for COVID-19, which has threatened the world recently, continue to be investigated. Although some of the treatments are promising, it is thought to be early to state that there is definitive treatment. Experiences and treatment protocol studies from treatment centers are still important. The aim of this study is to evaluate factors affecting the treatment process of the first cases followed in our clinic. Materials and methods: The consecutive hospitalized patients with COVID-19 pneumonia were analyzed in this retrospective and cross-sectional study. Data were recorded from the electronic and written files of patients. Results: Eighty-three patients …


Hepatitis A Susceptibility Parallels High Covid-19 Mortality, Fai̇k Sariali̇oğlu, Fatma Burcu Belen, Kadi̇r Mutlu Hayran Jan 2021

Hepatitis A Susceptibility Parallels High Covid-19 Mortality, Fai̇k Sariali̇oğlu, Fatma Burcu Belen, Kadi̇r Mutlu Hayran

Turkish Journal of Medical Sciences

Background/aim:COVID-19 has become the biggest health problem of this century. It has been hypothesized that immunity against hepatitis A virus (HAV) may provide protection from COVID- 19. Materials and methods: As of 10June 2020, the infection had spread to 213 countries, with 7.3 million people infected and 413,733 dead. This data was combined with the World Health Organization susceptibility classification on the worldwide prevalence of HAV, and the relationship between HAV susceptibility and COVID-19 mortality were analyzed. Results: When the data from 213 countries were analyzed, it was found that there was a significant increasing trend in COVID-19 mortality rates …


Outcome Of Noncritical Covid-19 Patients With Early Hospitalization And Early Antiviraltreatment Outside The Icu, Nursel Çalik Başaran, Oğuz Abdullah Uyaroğlu, Gülçi̇n Telli̇ Di̇zman, Lale Özişik, Taha Koray Şahi̇n, Zahi̇t Taş, Ahmet Çağkan İnkaya, Sevi̇lay Karahan, Şehnaz Özyavuz Alp, Alpaslan Alp, Gökhan Metan, Işkin Pinar Zarakol, Gülay Sai̇n Güven, Şeri̇fe Gül Öz, Arzu Topeli̇ İski̇t Jan 2021

Outcome Of Noncritical Covid-19 Patients With Early Hospitalization And Early Antiviraltreatment Outside The Icu, Nursel Çalik Başaran, Oğuz Abdullah Uyaroğlu, Gülçi̇n Telli̇ Di̇zman, Lale Özişik, Taha Koray Şahi̇n, Zahi̇t Taş, Ahmet Çağkan İnkaya, Sevi̇lay Karahan, Şehnaz Özyavuz Alp, Alpaslan Alp, Gökhan Metan, Işkin Pinar Zarakol, Gülay Sai̇n Güven, Şeri̇fe Gül Öz, Arzu Topeli̇ İski̇t

Turkish Journal of Medical Sciences

Background/aim: Despite the fact that the COVID-19 pandemic has been going on for over 5 months, there is yet to be a standard management policy for all patients including those with mild-to-moderate cases. We evaluated the role of early hospitalization in combination with early antiviral therapy with COVID-19 patients in a tertiary care university hospital. Materials and methods: This was a prospective, observational, single-center study on probable/confirmed COVID-19 patients hospitalized in a tertiary care hospital on COVID-19 wards between March 20 and April 30, 2020. The demographic, laboratory, and clinical data were collected. Results: We included 174 consecutive probable/confirmed COVID-19 …


Characteristics And Mortality Determinants Of Covid-19 Patients Undergoinghemodialysis, Savaş Si̇pahi̇, Hamad Dhei̇r, Aysel Toçoğlu, Meli̇ke Bektaş, Seyyi̇d Bi̇lal Açikgöz, Ahmed Ci̇had Genç, Fuldem Mutlu, Mehmet Köroğlu, Ali̇ Fuat Erdem, Oğuz Karabay Jan 2021

Characteristics And Mortality Determinants Of Covid-19 Patients Undergoinghemodialysis, Savaş Si̇pahi̇, Hamad Dhei̇r, Aysel Toçoğlu, Meli̇ke Bektaş, Seyyi̇d Bi̇lal Açikgöz, Ahmed Ci̇had Genç, Fuldem Mutlu, Mehmet Köroğlu, Ali̇ Fuat Erdem, Oğuz Karabay

Turkish Journal of Medical Sciences

Background/aim: The COVID-19 infection, which started in Wuhan City, China, in December 2019, turned into a pandemic in a very short time, affecting mainly the elderly and those with serious chronic illnesses. COVID-19 infections have been observed to have a high mortality rate, especially in patients undergoing maintenance hemodialysis. Materials and methods: Forty-two patients over 18 years of age who underwent a maintenance hemodialysis program at our unit, who tested positive for COVID-19 by PCR from nasopharyngeal swabs, and/or who were observed to have disease-related signs in their CTs were included in the study. Results: In this study, 23 of …


Treatment Of Sars-Cov-2 Pneumonia With Favipiravir: Early Results From The Egeuniversity Cohort, Turkey, Hüseyi̇n Aytaç Erdem, Pervi̇n Korkmaz Ekren, Derya Çağlayan, Meltem Taşbakan, Tansu Yamazhan, Mehmet Sezai̇ Taşbakan, Abdullah Sayiner, Ayşe Deni̇z Gökengi̇n Jan 2021

Treatment Of Sars-Cov-2 Pneumonia With Favipiravir: Early Results From The Egeuniversity Cohort, Turkey, Hüseyi̇n Aytaç Erdem, Pervi̇n Korkmaz Ekren, Derya Çağlayan, Meltem Taşbakan, Tansu Yamazhan, Mehmet Sezai̇ Taşbakan, Abdullah Sayiner, Ayşe Deni̇z Gökengi̇n

Turkish Journal of Medical Sciences

Background/aim: The aim of this descriptive article is to share the experience in Ege University, Turkey with favipiravir in the treatment of severe SARS-CoV-2 pneumonia. Materials and methods: This retrospective descriptive study included patients diagnosed with COVID-19 who presented with or developed severe pneumonia. Results: Forty patients who completed a full course (at least 5 days) of favipiravir were included in the study. At baseline, 30 (75%) patients required treatment for respiratory distress. Thirty-three patients (82.5%) were discharged from the hospital with full recovery, 6 patients (15%) died and 1 case (2.5%) was still at the intensive care unit (ICU) …